Anisochromia
Understanding Red Blood Cell Coloration
A normal red blood cell contains an adequate amount of hemoglobin, which gives it a uniform pink color with a slightly paler central area, representing about one-third of the cell's diameter. When the hemoglobin content decreases, the pale area gradually widens; this is called hypochromia. Conversely, a red blood cell denser in hemoglobin appears darker and lacks a clear central area, which is termed hyperchromia, observed notably in spherocytosis.
Anisochromia refers to the coexistence of erythrocytes with different colorations within the same smear. This heterogeneity reflects the simultaneous production of red blood cells under variable metabolic conditions, which occurs notably during the transition between two distinct hematological states.
Main causes
Anisochromia occurs in any context where the bone marrow simultaneously produces erythrocytes with different hemoglobin compositions. The most frequent causes are as follows.
| Cause | Mechanism | Typical clinical setting |
|---|---|---|
| Iron deficiency treatment. | Coexistence of old hypochromic erythrocytes and new normochromic red blood cells produced after correction | Patient on iron supplementation for 2 to 6 weeks |
| Early iron deficiency | Beginning of iron ore reserve depletion; production still mixed | Woman of childbearing age, frequent blood donor, vegan |
| Sideroblastic anemia | Defect in iron incorporation into heme despite adequate stores | Chronic alcoholism, lead poisoning, X-linked hereditary form |
| Mixed anemia (iron deficiency + vitamin B12 or folate deficiency) | Simultaneous production of hypochromic microcytes and normochromic macrocytes | Malnutrition, malabsorption, pregnancy, bariatric surgery |
| Recent blood transfusion | Mixing of donor and recipient erythrocytes with different characteristics | Immediate post-transfusion in a context of chronic anemia |
| Myelodysplasia | Ineffective erythropoiesis with heterogeneous cell production | Adult over 60 years old, unexplained cytopenias |
| Thalassemia minor | Reduced synthesis of globin chains; variable microcytosis and hypochromia | Mediterranean, Middle Eastern, Asian, or African origins |
Associated anomalies on peripheral blood smear
Anisochromia is rarely isolated. It most often occurs within a broader morphological picture that points to the underlying etiology. The overall interpretation of the smear includes the analysis of the following elements.
- Anisocytosis: Variation in the size of erythrocytes (microcytes, macrocytes)
- Poikilocytosis: variation in shape (target cells, elliptocytes, schistocytes)
- Presence of ring sideroblasts on Perls stain (sideroblastic anemia)
- Neutrophil hypersegmentation (vitamin B12 or folate deficiency)
- Reticulocytosis: indicates an active bone marrow response to anemia
- Reactive thrombocytosis frequently associated with iron deficiency
Additional biological parameters
The blood smear provides qualitative information that automated complete blood counts cannot fully replace. In the presence of anisochromia, an etiologic workup is indicated to identify the underlying deficiency(ies) and measure their severity.
| Parameter | Guiding value | Meaning |
|---|---|---|
| Serum ferritin | Low (< 15–30 µg/L) | Depletion of iron stores; the most sensitive marker of iron deficiency |
| Serum iron and transferrin saturation | Base (< 20 %) | Reduced iron availability for erythropoiesis |
| RDW (IDE) | High (> 14.5 %) | Red blood cell size heterogeneity; often correlates with anisochromia |
| MCV (mean corpuscular volume) | Low, normal, or high | Orient towards microcytosis, normocytosis, or macrocytosis depending on the cause |
| MCHC (Mean Corpuscular Hemoglobin Concentration) | Low (< 27 pg) | Confirm erythrocyte hypochromia |
| Vitamin B12 and folate | Bass | Associated deficiency in mixed anemia |
| Hemoglobin electrophoresis | Fraction Anomaly | Suspicion of thalassemia or hemoglobinopathy |
| Reticulocytes | High or low depending on the context | Assess the medullary response and differentiate between a regenerative or aregenerative anemia |
Support according to etiology
The treatment for anisocytosis is to treat its cause. There is no specific treatment for the color variation itself; it disappears as the underlying abnormality is corrected. A hematologic reevaluation with CBC and smear is recommended 4 to 8 weeks after treatment to confirm the response.
- Iron deficiency: oral supplementation with ferrous sulfate or gluconate; correction of the cause (bleeding, malabsorption)
- Vitamin B12 deficiency: intramuscular cyanocobalamin injections or high-dose oral supplementation depending on the cause
- Folate Deficiency: Oral Folic Acid; Correction of Nutritional or Drug Factors
- Acquired sideroblastic anemia: removal of the causal factor (alcohol, medication, toxin); pyridoxine in responsive forms
- Minor thalassemia: genetic counseling, monitoring; no iron treatment unless proven deficiency
- Myelodysplasia: Hematology reference for staging and specialized treatment
Tracking and monitoring
An anisochromia incidentally discovered on a routine CBC should not be ignored, even in the absence of symptoms. Correcting an identified nutritional deficiency is generally simple and effective, but biological monitoring is essential to confirm the response to treatment and rule out a more serious underlying cause. In the absence of normalization upon re-evaluation, further investigation, including specialist hematology consultation, is warranted.
Consult at Clinique Omicron
Clinique Omicron has, at its service points in Quebec, a medical team capable of evaluating and interpreting anisocytosis identified on a complete blood count. Our doctors will conduct a detailed medical history, prescribe the appropriate etiological workup, and monitor the response to treatment. Whether it's correcting a nutritional deficiency or an hematological abnormality requiring referral to a specialist, our teams are available for consultation at one of our service points on the South Shore or in one of our branches in Quebec, as well as via teleconsultation for an initial evaluation.
The content of this page is provided for informational purposes only and is not intended to replace the advice of a qualified healthcare professional. Consult a physician for any symptoms, questions or decisions you may have regarding your health.
Omicron Clinic
Need to consult a doctor?
Treatment within 24-48 hours. In-clinic or telemedicine, anywhere in Quebec.
Insurance receipts. 7j/7. No family doctor required.